Table 1.
The baseline characteristics and fat measurements of patients stratified by T stage
| Variable | Total (n = 253) |
T12 (n = 178) |
T34 (n = 75) |
p | p* |
|---|---|---|---|---|---|
| Age, year | 59.63 ± 10.75 | 57.97 (10.86) | 63.56 (9.43) | <0.001a | |
| Sex, n (%) Female |
|||||
| 71 (28.06) | 59 (33.15) | 12 (16.00) | 0.009b | ||
| Male | 182 (71.94) | 119 (66.85) | 63 (84.00) | ||
| BMI | 25.50 ± 3.92 | 25.64 ± 3.83 | 24.38 ± 4.60 | 0.293a | 0.441d |
| VFA, cm2 | 143.91 ± 64.32 | 136.74 ± 60.76 | 160.94 ± 69.57 | 0.010a | |
| SFA, cm2 | 185.70 ± 78.67 | 195.04 ± 79.88 | 163.53 ± 71.43 | 0.004 c | |
| TFA, cm2 | 329.61 ± 120.58 | 331.78 ± 116.52 | 324.47 ± 130.38 | 0.675a | |
| rVFA, % | 43.61 ± 10.48 | 41.11 ± 10.51 | 49.55 ± 7.69 | <0.001 c | <0.001d |
p< 0.05 is indicated by boldface
aStudent’s t-test; bChi-squared test; cMann–Whitney U test; dGeneral Linear Model; *adjusted p value
ccRCC: clear cell renal cell carcinoma; BMI: body mass index; VFA: visceral fat area; SFA: subcutaneous fat area; TFA: total fat area; rVFA: relative visceral fat area